Rapid Changes in Laboratory Parameters and Early Response to Adalimumab: A Pooled Analysis From Patients With Ulcerative Colitis in Two Clinical Trials

MLA

Stephen B. Hanauer, et al. “Rapid Changes in Laboratory Parameters and Early Response to Adalimumab: A Pooled Analysis From Patients With Ulcerative Colitis in Two Clinical Trials.” Journal of Crohn’s and Colitis, vol. 13, Feb. 2019, pp. 1227–33. EBSCOhost, https://doi.org/10.1093/ecco-jcc/jjz031.

APA

Stephen B. Hanauer, Kristina Kligys, William J. Sandborn, Jean-Frederic Colombel, J Petersson, Severine Vermeire, Qian Zhou, Andreas Lazar, & Walter Reinisch. (2019). Rapid Changes in Laboratory Parameters and Early Response to Adalimumab: A Pooled Analysis From Patients With Ulcerative Colitis in Two Clinical Trials. Journal of Crohn’s and Colitis, 13, 1227–1233. https://doi.org/10.1093/ecco-jcc/jjz031

Chicago

Stephen B. Hanauer, Kristina Kligys, William J. Sandborn, Jean-Frederic Colombel, J Petersson, Severine Vermeire, Qian Zhou, Andreas Lazar, and Walter Reinisch. 2019. “Rapid Changes in Laboratory Parameters and Early Response to Adalimumab: A Pooled Analysis From Patients With Ulcerative Colitis in Two Clinical Trials.” Journal of Crohn’s and Colitis 13 (February): 1227–33. doi:10.1093/ecco-jcc/jjz031.